Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IDEX.OL Stock Summary
Top 10 Correlated ETFs
IDEX.OL
In the News
IDEX.OL Financial details
Company Rating
Sell
Market Cap
699.82M
Income
-30.88M
Revenue
4.7M
Book val./share
0.02
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
69
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-10.12
Forward P/E
5.15
PEG
4.61
P/S
14.1
P/B
15.95
P/C
273
P/FCF
-2.14
Quick Ratio
2.25
Current Ratio
3.63
Debt / Equity
0.11
LT Debt / Equity
0.08
-
-
EPS (TTM)
-0.03
EPS next Y
0.53
EPS next Q
-0.15
EPS this Y
-8.67%
EPS next Y
-2076.15%
EPS next 5Y
-2076.15%
EPS last 5Y
-9.48%
Revenue last 5Y
74.86%
Revenue Q/Q
17.79%
EPS Q/Q
-8.06%
-
-
-
-
SMA20
32.74%
SMA50
-10.08%
SMA100
12.06%
Inst Own
-
Inst Trans
-
ROA
-114%
ROE
-168%
ROC
-1.41%
Gross Margin
24%
Oper. Margin
-635%
Profit Margin
-657%
Payout
-
Shs Outstand
279.76M
Shs Float
187.15M
-
-
-
-
Target Price
-
52W Range
1.26-5.45
52W High
-45.4%
52W Low
+173%
RSI
70.58
Rel Volume
2.29
Avg Volume
1.35M
Volume
3.09M
Perf Week
50%
Perf Month
52.51%
Perf Quarter
28.17%
Perf Half Y
15.68%
-
-
-
-
Beta
1.977
-
-
Volatility
0.32%, 0.42%
Prev Close
5%
Price
2.73
Change
0.37%
IDEX.OL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.05 | 0 | -0.03 | -0.03 | -0.03 | |
Operating cash flow per share | -0.05 | 0 | -0.03 | -0.03 | -0.03 | |
Free cash flow per share | -0.05 | 0 | -0.03 | -0.03 | -0.03 | |
Cash per share | 0.02 | 0 | 0.01 | 0.04 | 0.02 | |
Book value per share | 0.03 | 0 | 0.02 | 0.04 | 0.02 | |
Tangible book value per share | 0.02 | 0 | 0.01 | 0.04 | 0.02 | |
Share holders equity per share | 0.03 | 0 | 0.02 | 0.04 | 0.02 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 8.82B | 0 | 1.34B | 1.69B | 522.14M | |
Enterprise value | 8.81B | -12.63M | 1.34B | 1.65B | 507.56M | |
P/E ratio | -312.26 | 0 | -50.21 | -51.86 | -15.99 | |
Price to sales ratio | 35.23K | 0 | 1.23K | 594.46 | 127.6 | |
POCF ratio | -358.47 | 0 | -57.67 | -61.47 | -16.37 | |
PFCF ratio | -344.04 | 0 | -56.85 | -61.16 | -16.23 | |
P/B Ratio | 623.56 | 0 | 107.34 | 44.75 | 22.86 | |
PTB ratio | 623.56 | 0 | 107.34 | 44.75 | 22.86 | |
EV to sales | 35.2K | -79.78 | 1.22K | 582.69 | 124.04 | |
Enterprise value over EBITDA | -324 | 0.42 | -54.23 | -56.03 | -16.96 | |
EV to operating cash flow | -358.08 | 0.46 | -57.4 | -60.25 | -15.91 | |
EV to free cash flow | -343.66 | 0.44 | -56.59 | -59.95 | -15.78 | |
Earnings yield | 0 | 0 | -0.02 | -0.02 | -0.06 | |
Free cash flow yield | 0 | 0 | -0.02 | -0.02 | -0.06 | |
Debt to equity | 0 | 0.08 | 0.08 | 0.01 | 0.07 | |
Debt to assets | 0 | 0.06 | 0.06 | 0.01 | 0.05 | |
Net debt to EBITDA | 0.35 | 0.42 | 0.25 | 1.13 | 0.49 | |
Current ratio | 3.21 | 3.27 | 2.6 | 8.5 | 4.74 | |
Interest coverage | -17.39K | 0 | -55.35 | -1.01K | -950.58 | |
Income quality | 0.87 | 0.86 | 0.87 | 0.85 | 0.98 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 73.81 | 0 | 18.79 | 7.43 | 4.7 | |
Research and developement to revenue | 21.02 | 27.64 | 1.73 | 0.94 | 0.79 | |
Intangibles to total assets | 0.22 | 0.15 | 0.2 | 0.07 | 0.08 | |
Capex to operating cash flow | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | |
Capex to revenue | -4.12 | -5.36 | -0.3 | -0.05 | -0.07 | |
Capex to depreciation | -1.31 | -0.52 | -0.19 | -0.08 | -0.2 | |
Stock based compensation to revenue | 11.08 | 15.96 | 2.52 | 0.97 | 0.53 | |
Graham number | 0.17 | 0 | 0.11 | 0.18 | 0.13 | |
ROIC | -1.98 | -1.57 | -1.8 | -0.82 | -1.21 | |
Return on tangible assets | -2.03 | -1.63 | -1.97 | -0.83 | -1.23 | |
Graham Net | 0.01 | 0 | 0.01 | 0.03 | 0.01 | |
Working capital | 8.33M | 11.32M | 6.67M | 33.05M | 18.8M | |
Tangible asset value | 10.13M | 14.2M | 9.1M | 34.79M | 20.39M | |
Net current asset value | 8.31M | 10.68M | 6.35M | 33.05M | 17.66M | |
Invested capital | 0 | 0.08 | 0.08 | 0.01 | 0.07 | |
Average receivables | 620.66K | 1.15M | 1.63M | 1.6M | 1.91M | |
Average payables | 480.01K | 524.46K | 545.78K | 658K | 1.11M | |
Average inventory | 1.15M | 924.94K | 771.13K | 1.05M | 2.84M | |
Days sales outstanding | 1.01K | 3.71K | 550 | 198.05 | 203.19 | |
Days payables outstanding | 1.25K | 2.71K | 837.51 | 199.38 | 173.27 | |
Days of inventory on hand | 2.47K | 4.02K | 1.14K | 359.18 | 500.36 | |
Receivables turnover | 0.36 | 0.1 | 0.66 | 1.84 | 1.8 | |
Payables turnover | 0.29 | 0.13 | 0.44 | 1.83 | 2.11 | |
Inventory turnover | 0.15 | 0.09 | 0.32 | 1.02 | 0.73 | |
ROE | -2 | -1.82 | -2.14 | -0.86 | -1.43 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.01 | 0 | -0.01 | -0.01 | |
Operating cash flow per share | -0.01 | -0.01 | 0 | -0.01 | -0.01 | |
Free cash flow per share | -0.01 | -0.01 | 0 | -0.01 | -0.01 | |
Cash per share | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Book value per share | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | |
Tangible book value per share | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Share holders equity per share | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 542.21M | 320.36M | 766.4M | 556.26M | 428.15M | |
Enterprise value | 526.01M | 311.99M | 751.82M | 550.41M | 419.34M | |
P/E ratio | -13.32 | -8.07 | -30.54 | -19.21 | -14.38 | |
Price to sales ratio | 489.36 | 345.21 | 718.28 | 447.87 | 292.66 | |
POCF ratio | -60.11 | -44.14 | -106.37 | -62.01 | -59.99 | |
PFCF ratio | -59.77 | -43.47 | -105.59 | -62.01 | -58.44 | |
P/B Ratio | 23.79 | 21.51 | 33.55 | 34.81 | 21.84 | |
PTB ratio | 23.79 | 21.51 | 33.55 | 34.81 | 21.84 | |
EV to sales | 474.74 | 336.2 | 704.61 | 443.16 | 286.63 | |
Enterprise value over EBITDA | -66.11 | -40.24 | -114.19 | -78.9 | -60.65 | |
EV to operating cash flow | -58.32 | -42.99 | -104.35 | -61.36 | -58.76 | |
EV to free cash flow | -57.99 | -42.34 | -103.59 | -61.36 | -57.23 | |
Earnings yield | -0.02 | -0.03 | -0.01 | -0.01 | -0.02 | |
Free cash flow yield | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | |
Debt to equity | 0.01 | 0.05 | 0.07 | 0.1 | 0.11 | |
Debt to assets | 0 | 0.04 | 0.05 | 0.07 | 0.08 | |
Net debt to EBITDA | 2.04 | 1.08 | 2.21 | 0.84 | 1.27 | |
Current ratio | 7.85 | 4.07 | 4.74 | 3.77 | 3.63 | |
Interest coverage | -8.31K | -812.1 | -385.5 | -308.63 | -163.76 | |
Income quality | 0.98 | 0.8 | 1.14 | 1.24 | 0.95 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 4.31 | 5.48 | 4.1 | 3.55 | 2.71 | |
Research and developement to revenue | 0.86 | 1.11 | 0.22 | 0.75 | 0.58 | |
Intangibles to total assets | 0.11 | 0.14 | 0.08 | 0.11 | 0.08 | |
Capex to operating cash flow | 0.01 | 0.02 | 0.01 | 0 | 0.03 | |
Capex to revenue | -0.05 | -0.12 | -0.05 | 0 | -0.13 | |
Capex to depreciation | -0.15 | -0.34 | -0.17 | 0 | -0.47 | |
Stock based compensation to revenue | 0.54 | 0.41 | 0.38 | 0.32 | 0.22 | |
Graham number | 0.08 | 0.06 | 0.04 | 0.04 | 0.04 | |
ROIC | -0.4 | -0.55 | -0.27 | -0.39 | -0.31 | |
Return on tangible assets | -0.45 | -0.62 | -0.24 | -0.37 | -0.3 | |
Graham Net | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Working capital | 18.76M | 10.75M | 18.8M | 12.34M | 15.68M | |
Tangible asset value | 20.1M | 12.32M | 20.39M | 13.64M | 17.39M | |
Net current asset value | 18.76M | 10.43M | 17.66M | 11.08M | 14.16M | |
Invested capital | 0.01 | 0.05 | 0.07 | 0.1 | 0.11 | |
Average receivables | 2M | 1.64M | 1.77M | 2.21M | 2.28M | |
Average payables | 702.5K | 635K | 1.11M | 1.29M | 1.02M | |
Average inventory | 2.02M | 2.48M | 3.69M | 4.88M | 5.89M | |
Days sales outstanding | 164.65 | 121.81 | 192.15 | 154.71 | 149.36 | |
Days payables outstanding | 51.53 | 74.51 | 193.85 | 103.21 | 78.05 | |
Days of inventory on hand | 176.08 | 321.65 | 559.76 | 524.42 | 508.24 | |
Receivables turnover | 0.55 | 0.74 | 0.47 | 0.58 | 0.6 | |
Payables turnover | 1.75 | 1.21 | 0.46 | 0.87 | 1.15 | |
Inventory turnover | 0.51 | 0.28 | 0.16 | 0.17 | 0.18 | |
ROE | -0.45 | -0.67 | -0.27 | -0.45 | -0.38 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
IDEX.OL Frequently Asked Questions
What is IDEX Biometrics ASA stock symbol ?
IDEX Biometrics ASA is a NO stock and trading under the symbol IDEX.OL
What is IDEX Biometrics ASA stock quote today ?
IDEX Biometrics ASA stock price is $2.73 today.
Is IDEX Biometrics ASA stock public?
Yes, IDEX Biometrics ASA is a publicly traded company.